AB Soft The Brief Pain Inventory ii - Manual (Page 16)

27
morphine pre-treated and opioid naive patients with
transdermal fentanyl. Int J Cancer 107(3): 486-492, 11/2003.
46. Mystakidou K, Parpa E, Katsouda E, Galanos A, Vlahos L.
Influence of pain and quality of life on desire for hastened
death in patients with advanced cancer. Int J Palliat Nurs
10(10): 476-483, 10/2004.
47. Mystakidou K, Parpa E, Tsilika E, Katsouda E, Kouloulias V,
Kouvaris J, Georgaki S, Vlahos L. Pain management of cancer
patients with transdermal fentanyl: a study of 1828 step I, II, &
III transfers. J Pain 5(2): 119-132, 3/2004.
48. Mystakidou K, Rosenfeld B, Parpa E, Katsouda E, Tsilika E,
Galanos A, Vlahos L. Desire for death near the end of life: the
role of depression, anxiety and pain. Gen Hosp Psychiatry
27(4): 258-262, 7/2005.
49. Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A,
Vlahos L. Psychological distress of patients with advanced
cancer: influence and contribution of pain severity and pain
interference. Cancer Nurs 29(5): 400-405, 9/2006.
50. Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Patiraki E, Galanos
A, Vlahos L. Sleep quality in advanced cancer patients. J
Psychosom Res 62(5): 527-533, 5/2007.
51. Nie J, Liu S, Di L. [Cancer pain and its influence on cancer
patients' quality of life]. Zhonghua Zhong Liu Za Zhi 22(5): 432-
434, 9/2000.
52. O'Mahony S, Goulet J, Kornblith A, Abbatiello G, Clarke B,
Kless-Siegel S, Breitbart W, Payne R. Desire for hastened death,
cancer pain and depression: report of a longitudinal
observational study. J Pain Symptom Manage 29(5): 446-457,
5/2005.
53. Owen JE, Klapow JC, Casebeer L. Evaluating the relationship
between pain presentation and health-related quality of life
in outpatients with metastatic or recurrent neoplastic disease.
Qual Life Res 9(7): 855-863, 2000.
54. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE,
Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE,
28
Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi
PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman
CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR,
Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP,
Cotton DJ, Gnann JW, Jr., Loutit J, Holodniy M, Keitel WA,
Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller
PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan
CY, Chan IS, Wang WW, Annunziato PW, Silber JL. A vaccine
to prevent herpes zoster and postherpetic neuralgia in older
adults. N Engl J Med 352(22): 2271-2284, 6/2005.
55. Palangio M, Northfelt DW, Portenoy RK, Brookoff D, Doyle RT,
Jr., Dornseif BE, Damask MC. Dose conversion and titration
with a novel, once-daily, OROS osmotic technology,
extended-release hydromorphone formulation in the
treatment of chronic malignant or nonmalignant pain. J Pain
Symptom Manage 23(5): 355-368, 5/2002.
56. Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R,
Mahmoud R. Quality of life and cancer pain: satisfaction and
side effects with transdermal fentanyl versus oral morphine. J
Clin Oncol 16(4): 1588-1593, 4/1998.
57. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain:
characteristics and impact in patients with cancer pain. Pain
81(1-2): 129-134, 5/1999.
58. Poulos AR, Gertz MA, Pankratz VS, Post-White J. Pain, mood
disturbance, and quality of life in patients with multiple
myeloma. Oncol Nurs Forum 28(7): 1163-1171, 8/2001.
59. Reyes-Gibby CC, Ba DN, Phi YN, Hoai NN, Van TT, Guo H, Bhat
S, Cleeland C. Status of cancer pain in Hanoi, Vietnam: A
hospital-wide survey in a tertiary cancer treatment center. J
Pain Symptom Manage 31(5): 431-439, 5/2006.
60. Rodin G, Zimmermann C, Rydall A, Jones J, Shepherd FA,
Moore M, Fruh M, Donner A, Gagliese L. The desire for
hastened death in patients with metastatic cancer. J Pain
Symptom Manage 33(6): 661-675, 6/2007.
61. Sandblom G, Carlsson P, Sigsjo P, Varenhorst E. Pain and
health-related quality of life in a geographically defined